Environment, Social, and Governance

Partner Content

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval

Rusan Pharma's new facility in India will enhance its global capabilities, expand its API product portfolio, and increase its presence in the US pharmaceutical sector.

Features

Pharma readies for climate disasters amidst supply chain concerns

News

Signal: NHS whistle-blower policy questioned following Letby conviction

News

Parker Review publishes FTSE 350 firms’ ethnic diversity targets in the UK

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval

Pharma readies for climate disasters amidst supply chain concerns

Signal: NHS whistle-blower policy questioned following Letby conviction

Parker Review publishes FTSE 350 firms’ ethnic diversity targets in the UK

Leading lead generation providers and technology solutions for the pharmaceutical industry

Leading sales enablement, prospecting and automation providers and technology solutions for the pharmaceutical industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief